share_log

StockNews.com Initiates Coverage on Blonder Tongue Laboratories (NYSE:BDR)

Defense World ·  Jul 24, 2022 14:11

StockNews.com initiated coverage on shares of Blonder Tongue Laboratories (NYSE:BDR – Get Rating) in a note issued to investors on Sunday. The brokerage set a "hold" rating on the stock.

Blonder Tongue Laboratories Price Performance

The stock has a market capitalization of $4.13 million, a PE ratio of -4.43 and a beta of 0.55. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.11 and a quick ratio of 0.38. Blonder Tongue Laboratories has a 1-year low of $0.28 and a 1-year high of $1.91. The business's fifty day moving average price is $0.36.

Get Blonder Tongue Laboratories alerts:

Blonder Tongue Laboratories (NYSE:BDR – Get Rating) last posted its earnings results on Friday, May 6th. The company reported ($0.09) earnings per share (EPS) for the quarter. The business had revenue of $3.34 million for the quarter. Blonder Tongue Laboratories had a negative net margin of 4.14% and a negative return on equity of 18.69%.

About Blonder Tongue Laboratories

(Get Rating)

Blonder Tongue Laboratories, Inc, a technology-development and manufacturing company, provides television (TV) signal encoding, transcoding, digital transport, and broadband product solutions in the United States. It offers encoders/transcoders, such as 4K/ultra-high definition, high definition and standard definition, MPEG-2, MPEG-4/H.264, and HEVC/H.265 capable encoders and transcoders; and QPSK and 8PSK, and QAM transcoders.

Recommended Stories

  • Get a free copy of the StockNews.com research report on Blonder Tongue Laboratories (BDR)
  • Three Watchlist Stocks to Capitalize on Sector Rotation
  • MarketBeat: Week in Review 7/18 – 7/22
  • Falling Copper Prices Weigh On Freeport McMoran's Earnings, But Long Term Fundamentals Intact
  • Snap Stock Falters As Growth Slows To Record Low
  • Lackluster Results Provide An Opportunity In Tractor Supply Company

Receive News & Ratings for Blonder Tongue Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blonder Tongue Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment